Crestline Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,592	Closed	-$2.05M	–	130
2017 Q2	$2.05M	Sell	22,592 -2,207	-9%	-$200K	0.27%	40
2017 Q1	$2.18M	Buy	24,799 +17,106	+222%	+$1.5M	0.4%	27
2016 Q4	$637K	Buy	7,693 +3,051	+66%	+$253K	0.16%	46
2016 Q3	$429K	Buy	+4,642	New	+$429K	0.05%	155